| SC 13G/A | 2023-04-28 | Sessa Capital (Master), L.P. | Provention Bio, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-04-05 | Sessa Capital (Master), L.P. | Provention Bio, Inc. | 17,758,046 | 17.1% | EDGAR |
| SC 13G | 2023-02-21 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Provention Bio, Inc. | 5,398,825 | 6.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Venrock Healthcare Capital Partners II, L.P. | Provention Bio, Inc. | 1,118,653 | 1.3% | EDGAR |
| SC 13G/A | 2023-02-14 | Sessa Capital (Master), L.P. | Provention Bio, Inc. | 18,066,613 | 20.0% | EDGAR |
| SC 13G/A | 2023-02-09 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Provention Bio, Inc. | 2,519,257 | 2.9% | EDGAR |
| SC 13G/A | 2023-02-01 | BlackRock Inc. | Provention Bio, Inc. | 5,579,604 | 6.4% | EDGAR |
| SC 13G | 2022-08-26 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Provention Bio, Inc. | 5,300,000 | 6.5% | EDGAR |
| SC 13G/A | 2022-07-11 | Sessa Capital (Master), L.P. | Provention Bio, Inc. | 15,610,170 | 20.0% | EDGAR |
| SC 13G/A | 2022-02-14 | PERCEPTIVE ADVISORS LLC | Provention Bio, Inc. | 948,481 | 1.5% | EDGAR |
| SC 13G | 2022-02-14 | Sessa Capital (Master), L.P. | Provention Bio, Inc. | 5,895,525 | 9.3% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | Provention Bio, Inc. | 4,483,925 | 7.1% | EDGAR |
| SC 13G | 2021-06-07 | Venrock Healthcare Capital Partners II, L.P. | Provention Bio, Inc. | 3,843,796 | 6.1% | EDGAR |
| SC 13G/A | 2021-04-19 | PERCEPTIVE ADVISORS LLC | Provention Bio, Inc. | 3,633,023 | 5.7% | EDGAR |
| SC 13G/A | 2021-02-16 | APPEL PETER A | Provention Bio, Inc. | 2,262,500 | 4.0% | EDGAR |
| SC 13G/A | 2021-02-16 | PERCEPTIVE ADVISORS LLC | Provention Bio, Inc. | 4,224,389 | 6.7% | EDGAR |
| SC 13G/A | 2021-02-05 | AMGEN INC | Provention Bio, Inc. | 2,500,000 | - | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | Provention Bio, Inc. | 3,925,489 | 6.9% | EDGAR |
| SC 13G/A | 2020-02-20 | MACROGENICS INC | Provention Bio, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-18 | PERCEPTIVE ADVISORS LLC | Provention Bio, Inc. | 2,921,574 | 6.1% | EDGAR |